Cardinal Health Raised Its Fiscal 2024 Adjusted EPS Guidance To $7.20-$7.35, From $6.75-$7.003 Versus Consensus Of $6.96
Portfolio Pulse from Benzinga Newsdesk
Cardinal Health has increased its fiscal 2024 adjusted EPS guidance to $7.20-$7.35, up from the previous forecast of $6.75-$7.00, surpassing the consensus estimate of $6.96.
February 01, 2024 | 11:53 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cardinal Health has revised its fiscal 2024 adjusted EPS guidance upwards to $7.20-$7.35 from $6.75-$7.00, exceeding analyst expectations of $6.96.
Raising the EPS guidance significantly above the consensus estimates indicates strong confidence in the company's financial health and operational efficiency. This is likely to be viewed positively by investors, potentially leading to an increase in stock price in the short term as market sentiment around the company improves.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100